Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Early Alzheimer's Disease Clinical Trial

Official title:
A Phase 2a, Proof-of-Concept, Open-Label Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Obicetrapib in Patients With Early Alzheimer's Disease (Hetero/Homozygote APOE4 Carriers)

Status Completed

Clinical Trial Summary

A Phase 2a study in men and women with early Alzheimer's disease to evaluate the pharmacodynamics, pharmacokinetics and safety of obicetrapib therapy.

Clinical Trial Description

This study will be a proof of concept, Phase 2a study in patients with early Alzheimer's disease (clinical diagnosis of Alzheimer's disease Stage 3 or 4 based on the National Institute on Aging Alzheimer's Association Research Framework criteria) to evaluate the Pharmacodynamic, cognitive effects, Pharmacokinetic, and safety and tolerability of obicetrapib therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05161715
Study type	Interventional
Source	NewAmsterdam Pharma
Contact
Status	Completed
Phase	Phase 2
Start date	January 12, 2022
Completion date	June 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04693520` - Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease	Phase 2
Recruiting	`NCT05122598` - Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease	Phase 2
Active, not recruiting	`NCT04770220` - An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects	Phase 3
Active, not recruiting	`NCT04777396` - A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)	Phase 3
Active, not recruiting	`NCT03887455` - A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease	Phase 3
Recruiting	`NCT05531656` - A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	Phase 2
Recruiting	`NCT04599764` - High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease	N/A
Completed	`NCT02859207` - A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects	Phase 1
Not yet recruiting	`NCT06304883` - Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects	Phase 3